Radiotherapy has long been a cornerstone of cancer treatment, lauded for its ability to not only target primary tumors but occasionally elicit the ‘abscopal effect,’ whereby local radiation leads to regression in tumors distant from the treatment site. However, recent findings suggest a more complex and potentially troubling side to its mechanism of action.
In a study published in a peer-reviewed journal, researchers have uncovered evidence that radiotherapy may inadvertently promote cancer metastasis by inducing the expression of the epidermal growth factor receptor (EGFR) ligand. The EGFR pathway is well-known for its role in cell growth and proliferation, and its activation has been linked to the progression and spread of several cancers.
The research focused on how radiation affects the tumor microenvironment and adjacent healthy tissues. It was found that radiation treatment led to elevated levels of EGFR ligands in both tumor and surrounding cells, potentially facilitating conditions that allow cancer cells to invade new tissues and form secondary tumors.
This discovery raises important questions about the balance between the therapeutic benefits of radiotherapy and its systemic effects on cancer biology. It also underscores the need for developing strategies that minimize the risk of metastasis while preserving the anti-tumor benefits of radiation.
Experts emphasize further research is required to fully understand the biological mechanisms involved and to explore potential co-therapies that might inhibit EGFR signaling during radiotherapy. These findings may open doors to more targeted treatment strategies, ensuring improved safety and efficacy for cancer patients undergoing radiation therapy.
Source: https:// – Courtesy of the original publisher.
